Client
CIRCALGAE
The CIRCALGAE consortium is coordinated by Chalmers University of Technology and brings together 21 organisations from 11 European countries, including algae producers, biotechnology companies, food and cosmetics manufacturers, research and technology organisations, universities and innovation consultancies.
Civitta is the consortium partner responsible for key activities related to sustainability, market analysis and exploitation. The project is funded under Horizon Europe, with a total project budget of approximately €10.27 million and an EU contribution of €8.51 million.
CIRCALGAE addresses an important untapped opportunity in the European blue bioeconomy: large quantities of biomass and residual streams generated by microalgae and macroalgae industries are currently underutilised.
The project applies a cascade biorefinery approach to transform these streams into high-value ingredients for food, feed and cosmetics, rather than treating them as waste or low-value by-products.
The project started in October 2022 and runs until September 2026 under the Horizon Europe call HORIZON-CL6-2021-CIRCBIO-01. Its ambition is to demonstrate three scalable blue biorefinery schemes, develop 12 demonstrator products and qualify two final products for the market, while assessing their environmental, economic and social implications.
CIRCALGAE needed to address both the technical and commercial barriers preventing the full valorisation of algae biomass and industrial side-streams:
Civitta combined market intelligence, sustainability assessment and economic analysis to connect CIRCALGAE’s technological innovations with viable business opportunities and credible pathways towards market uptake.
CIRCALGAE was successfully funded under Horizon Europe and launched in October 2022. By the second reporting period, the project had progressed from concept development towards pilot-scale demonstration: several extraction processes had been transferred to pilot scale, functional and bioactive ingredients had been produced from algae side-streams, and more than 30 prototype products had been developed and tested across food, feed and cosmetics.
The project is working towards three blue biorefinery schemes scaled to hundreds of kilograms, 12 demonstrator products and three products qualified for market, with environmental, economic, regulatory and consumer-acceptance aspects considered alongside technical performance.
The broader significance is the demonstration of a circular model in which residual algae biomass becomes a source of valuable proteins, fibres, pigments and other bioactive compounds, supporting new European value chains in the blue bioeconomy while reducing resource losses and waste.
CIRCALGAE demonstrates that circular bioeconomy innovations need to be evaluated as complete value chains rather than individual technologies. A promising extraction technology only creates meaningful impact when there is sufficient feedstock, a valuable end product, acceptable environmental performance, a viable cost structure and a market willing to adopt it.
Combining these perspectives early helps identify which innovation pathways have the strongest potential for scale-up and commercialisation.
The project also demonstrates our ability to bridge technology, sustainability and markets. By combining LCA and LCC with market intelligence and business-case development, Civitta helps research consortia move from “what can we produce?” towards the more commercially relevant questions of “where does it create value, under what conditions, and how can it be scaled sustainably?”